APA

Meier S., Pütz G., Massing U., Hagemeyer C. E., von Elverfeldt D., Meissner M., Ardipradja K., Barnert S., Peter K., Bode C., Schubert R. & von zur Muhlen C. (20160119). Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis. : Biomaterials.

Chicago

Meier S, Pütz G, Massing U, Hagemeyer C E, von Elverfeldt D, Meissner M, Ardipradja K, Barnert S, Peter K, Bode C, Schubert R and von zur Muhlen C. 20160119. Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis. : Biomaterials.

Harvard

Meier S., Pütz G., Massing U., Hagemeyer C. E., von Elverfeldt D., Meissner M., Ardipradja K., Barnert S., Peter K., Bode C., Schubert R. and von zur Muhlen C. (20160119). Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis. : Biomaterials.

MLA

Meier S, Pütz G, Massing U, Hagemeyer C E, von Elverfeldt D, Meissner M, Ardipradja K, Barnert S, Peter K, Bode C, Schubert R and von zur Muhlen C. Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis. : Biomaterials. 20160119.